BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7457288)

  • 21. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of humoral and cell-mediated immune response following typhoid vaccination in human volunteers.
    Rajagopalan P; Kumar R; Malaviya AN
    Clin Exp Immunol; 1982 Feb; 47(2):275-82. PubMed ID: 7075025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-directed immunity in human neuroblastoma.
    Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML
    Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and humoral responses in amoebic patients.
    Vinayak VK; Jain P; Gupta B; Kaushik SP; Sawhney S
    Trop Geogr Med; 1980 Dec; 32(4):298-302. PubMed ID: 7210167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the occurrence of circulating immune complexes in vascular diseases.
    Füst G; Szondy E; Székely J; Nánai I; Gerö S
    Atherosclerosis; 1978 Feb; 29(2):181-90. PubMed ID: 646847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lymphocyte blast transformation and leukocyte migration inhibition as indices of sensitization in atherosclerosis of the coronary arteries of the heart].
    Selivanov II; Khardaev EK
    Sov Med; 1979 Jan; (1):35-40. PubMed ID: 424858
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of cell-mediated immunity in acute hepatitis B in the leukocyte migration inhibition test].
    Traditi F; Rossi F; Cirelli A
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1548-51. PubMed ID: 821498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cell-mediated immune-phenomenona in progressive chronic polyarthritis].
    Wenz W; Schnabel I; Jäger L; Schramm G
    Z Gesamte Inn Med; 1975 Dec; 30(23):266-8. PubMed ID: 1224736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of experimental craniocerebral trauma on cell-mediated and humoral immunity reactions].
    Ormantaev KS; Nadirov BN; Beliaev NN; Zakir'ianova GK; Tleulieva RT
    Zh Vopr Neirokhir Im N N Burdenko; 1998; (4):27-9; discussion 29-30. PubMed ID: 9988889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
    Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular immune phenomenon in scleroderma].
    Fritz J; Sandhofer M
    Dermatologica; 1977; 154(3):129-37. PubMed ID: 852625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of autologous serum, Oradexon and heparin on the cell-mediated immune response in vascular diseases.
    Horváth M; Szondy E; Ladányi A
    Clin Exp Immunol; 1980 Sep; 41(3):521-6. PubMed ID: 7438565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular response in patients with post-infarction Dresser syndrome studied by the leukocyte migration inhibition test].
    Domaniewski J; Hoffmann A; Poddany K
    Pol Tyg Lek; 1988 Oct 17-24; 43(42-43):1363-5. PubMed ID: 3252200
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated immunity in subjects immunized with HLA antigens.
    Alföldy P; Gyódi E; Dombi E; Tóth T; Hollán SR
    Haematologia (Budap); 1977; 11(1-2):93-102. PubMed ID: 615092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cellular immune reaction against aggregated human gamma globulin in chronic polyarthritis].
    Rothenberger W; Thiele HG
    Verh Dtsch Ges Rheumatol; 1974; 3(0):46-7. PubMed ID: 4134650
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immune response against lipoproteins in arteriosclerosis].
    Szondy E; Horváth M; Mezey Z; Székely J; Lengyel E; Füst G
    Orv Hetil; 1983 Dec; 124(52):3163-6. PubMed ID: 6657262
    [No Abstract]   [Full Text] [Related]  

  • 38. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
    Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
    Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.